• Molecular NameSulfadiazine
  • SynonymSDA; Sulfadiazene; Sulfadiazin; Sulfanilamidopyrimidine; Sulfapirimidin; Sulfapyrimidin; Sulfapyrimidine; Sulphadiazine
  • Weight250.282
  • Drugbank_IDDB00359
  • ACS_NO68-35-9
  • Show 3D model
  • LogP (experiment)-0.09
  • LogP (predicted, AB/LogP v2.0)-0.05
  • pka6.5 (25°)
  • LogD (pH=7, predicted)-0.68
  • Solubility (experiment)0.0773 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.71
  • LogSw (predicted, AB/LogsW2.0)0.45
  • Sw (mg/ml) (predicted, ACD/Labs)1.24
  • No.of HBond Donors3
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds3
  • TPSA106.35
  • StatusFDA approved
  • AdministrationCream
  • PharmacologyIt eliminates bacteria that cause infections by stopping the production of folic acid inside the bacterial cell, and is commonly used to treat urinary tract infections (UTIs).
  • Absorption_value93.0
  • Absorption (description)N/A
  • Caco_2-6.33
  • Bioavailability90.0
  • Protein binding43.0
  • Volume of distribution (VD)0.3 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life6~17 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityOral LD50 in mouse is 1500 mg/kg.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A